Dr. Lal PathLabs Limited (LALPATHLAB.NS)

INR 3018.6

(-0.67%)

Total Liabilities Summary of Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited's latest annual total liabilities in 2023 was 5.7 Billion INR , down -16.82% from previous year.
Dr. Lal PathLabs Limited's latest quarterly total liabilities in 2024 Q2 was 5.62 Billion INR , up 129.82% from previous quarter.
Dr. Lal PathLabs Limited reported annual total liabilities of 6.86 Billion INR in 2022, down -15.28% from previous year.
Dr. Lal PathLabs Limited reported annual total liabilities of 8.09 Billion INR in 2021, up 110.14% from previous year.
Dr. Lal PathLabs Limited reported quarterly total liabilities of 5.62 Billion INR for 2024 Q2, up 129.82% from previous quarter.
Dr. Lal PathLabs Limited reported quarterly total liabilities of 5.7 Billion INR for 2023 FY, down -16.82% from previous quarter.

Annual Total Liabilities Chart of Dr. Lal PathLabs Limited (2023 - 2010)

Historical Annual Total Liabilities of Dr. Lal PathLabs Limited (2023 - 2010)

Year	Total Liabilities	Total Liabilities Growth
2023	5.7 Billion INR	-16.82%
2022	6.86 Billion INR	-15.28%
2021	8.09 Billion INR	110.14%
2020	3.85 Billion INR	20.31%
2019	3.2 Billion INR	129.56%
2018	1.39 Billion INR	12.6%
2017	1.23 Billion INR	21.5%
2016	1.01 Billion INR	-11.88%
2015	1.15 Billion INR	-12.29%
2014	1.31 Billion INR	11.63%
2013	1.18 Billion INR	12.19%
2012	1.05 Billion INR	75.66%
2011	599.73 Million INR	-21.25%
2010	761.59 Million INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	-18.85 Billion INR	-430.42%
2024 Q2	5.62 Billion INR	129.82%
2023 FY	5.7 Billion INR	-16.82%
2023 Q1	- INR	-100.0%
2023 Q3	- INR	-100.0%
2023 Q2	6.39 Billion INR	0.0%
2023 Q4	5.7 Billion INR	0.0%
2022 Q2	7.19 Billion INR	0.0%
2022 Q4	6.86 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2022 FY	6.86 Billion INR	-15.28%
2022 Q3	- INR	-100.0%
2021 Q3	- INR	-100.0%
2021 Q1	- INR	-100.0%
2021 FY	8.09 Billion INR	110.14%
2021 Q4	8.09 Billion INR	0.0%
2021 Q2	4.5 Billion INR	0.0%
2020 Q3	- INR	-100.0%
2020 Q4	3.85 Billion INR	0.0%
2020 Q2	3.37 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	3.85 Billion INR	20.31%
2019 Q1	- INR	-100.0%
2019 Q3	- INR	-100.0%
2019 FY	3.2 Billion INR	129.56%
2019 Q4	3.2 Billion INR	0.0%
2019 Q2	2.89 Billion INR	0.0%
2018 Q2	1.52 Billion INR	0.0%
2018 FY	1.39 Billion INR	12.6%
2018 Q4	1.39 Billion INR	0.0%
2018 Q3	- INR	-100.0%
2018 Q1	- INR	-100.0%
2017 FY	1.23 Billion INR	21.5%
2017 Q1	- INR	-100.0%
2017 Q2	1.27 Billion INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	1.23 Billion INR	0.0%
2016 FY	1.01 Billion INR	-11.88%
2016 Q3	- INR	-100.0%
2016 Q4	1.01 Billion INR	0.0%
2016 Q2	1.37 Billion INR	0.0%
2016 Q1	- INR	-100.0%
2015 Q4	1.15 Billion INR	0.0%
2015 Q2	1.67 Billion INR	0.0%
2015 Q1	- INR	-100.0%
2015 FY	1.15 Billion INR	-12.29%
2014 FY	1.31 Billion INR	11.63%
2014 Q4	1.31 Billion INR	0.0%
2013 FY	1.18 Billion INR	12.19%
2012 FY	1.05 Billion INR	75.66%
2011 FY	599.73 Million INR	-21.25%
2010 FY	761.59 Million INR	0.0%

Peer Total Liabilities Comparison of Dr. Lal PathLabs Limited

Name	Total Liabilities	Total Liabilities Difference
Krsnaa Diagnostics Limited	3.62 Billion INR	-57.576%
Metropolis Healthcare Limited	4.55 Billion INR	-25.19%
Thyrocare Technologies Limited	1.16 Billion INR	-390.839%
Vijaya Diagnostic Centre Limited	3.22 Billion INR	-76.743%
Vimta Labs Limited	803.54 Million INR	-610.108%